(MedPage Today) — Energizing lazy eyes, how BPA affects human reproduction, immunizing against UTI, and promising but early studies in rheumatology highlight this week’s Lab Notes.
(MedPage Today) — Long-term use of vitamins C and E had no visible effect on the incidence of cataract in older men, researchers reported.
(MedPage Today) — Patients with glaucoma are at significantly increased risk for other serious comorbidities such as hypertension, diabetes, and mental illnesses, Taiwanese researchers found.
(MedPage Today) — Experimenting with “poppers” — inhaled alkyl nitrates used as recreational drugs — can cause lasting retinal damage, ophthalmologists warned.
CHICAGO (MedPage Today) — With the baby-boom generation now firmly in the age range when near-range vision goes blurry, advances in refractive surgery and implants could allow many of them to do away with reading glasses, researchers said here.
CHICAGO (MedPage Today) — Most ophthalmologists do not rely on evidence-based treatment guidelines for uveitis and, perhaps as a result, their practice patterns often deviated substantially from the recommendations, a survey showed.
CHICAGO (MedPage Today) — The first of a promising new class of glaucoma drugs reduced intraocular pressure and, perhaps more importantly, was additive with a current standard medication in a phase II trial, it was reported here.
CHICAGO (MedPage Today) — Diabetic retinopathy may be added to the list of conditions potentially related to vitamin D insufficiency, a researcher said here.
CHICAGO (MedPage Today) — Many long-term survivors with diabetes show little or no progression of retinopathy after a certain point, and this resistance apparently has nothing to do with glycemic control, a researcher said here.
CHICAGO (MedPage Today) — When children suffer eye injuries from dog bites, treatment often becomes much more complicated with multiple surgeries and long recovery periods, a researcher said here.
CHICAGO (MedPage Today) — More than half of Medicare patients prescribed a biologic for age-related macular degeneration (AMD) are getting bevacizumab (Avastin) off-label rather than ranibizumab (Lucentis), which is approved for the condition, researc…
CHICAGO (MedPage Today) — Although most preterm babies with retinopathy of prematurity (ROP) can have their sight saved if the condition is detected promptly, that fails to happen in far too many cases, a researcher charges in this exclusive InFocus r…
CHICAGO (MedPage Today) — Fenretinide could still become the first disease-modifying treatment for geographic atrophy — the end stage of “dry” age-related macular degeneration (AMD) — in spite of a bungled phase II trial, researchers said here.
CHICAGO (MedPage Today) — Drugs approved for “wet” age-related macular degeneration also appeared to be effective in diabetic macular edema in several clinical studies, researchers said here.
CHICAGO (MedPage Today) — A tiny array of light-sensing diodes restored a measure of sight to a small number of patients with retinitis pigmentosa, a researcher said here.
(MedPage Today) — Marked increases have occurred in the number of retinal procedures since the late 1990s, particularly with the wide acceptance of intravitreal injections for age-related macular degeneration, researchers found.
(MedPage Today) — Using vascular endothelial growth factor (VEGF) blockers to treat neovascular age-related macular degeneration does not appear to increase the risk of serious cardiovascular events, a retrospective study showed.
(MedPage Today) — Photoscreening can be a cost-effective way to detect amblyopia in preschool children, researchers affirmed.